Cytotoxic T lymphocytes are the body’s specialized “killer” cells, precisely eliminating infected or cancerous cells. Their ...

The Pentagon’s fiscal 2027 budget request is the clearest signal yet that the U.S. Space Force is moving into a new role: ...

Discover the technology behind the Active Denial System (ADS), often referred to as the "Beam of Pain," a cutting-edge non-lethal weapon developed under the Weapon of Effects Program. This video ...

IDFC First Bank gained 4.79 per cent to close at Rs 70.45 after its Q4 FY26 earnings triggered mixed brokerage views, with ...

Sean McGovern was involved in surveilling an ‘active target for assassination’ for the Kinahan organised crime group, a court has heard.

AlphaPepe presale stages are selling out in days as Stage 14 moves through its latest price window ahead of the Q2 2026 ...

On April 14, BofA lowered the firm’s price recommendation on Chubb Limited (NYSE:CB) to $271 from $286. It reiterated an Underperform rating on the shares. The firm made the adjustment across its U.S.

Add Futurism (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results. Big box ...

Engaging in mentally active behaviors, such as office work and knitting, while sedentary was associated with significantly lower dementia risk than mentally passive behavior, such as watching ...

A stormy weather pattern is taking hold across the Central U.s. and is expected to persist through at least the first half of April. A first round of severe storms rumbled through parts of the Midwest ...

Former Benchmark AMC co-founders Rajan Mehta and Sanjiv Shah are returning to the mutual fund industry after over 14 years. The target is on new, differentiated products. Will the strategy pay off?

The investment vehicle has reached new highs and can significantly benefit asset managers. Investors continue to invest their retirement savings in target-date funds. As the preferred investment ...